CClinicalTrials.gg
Sign In
CompletedNCT00813280Updated Nov 26, 2015

Barriers to the Implementation of Complete Insulin Order Sets

An observational study in Hyperglycemia, sponsored by HealthPartners Institute. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2015-11-26.

Sponsored by HealthPartners Institute · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
200
Ages
18 Years and older
Sex
All
01

Study summary

The major purpose of this Quality Improvement project is to begin to address the issues surrounding glycemic control in the hospital setting by collecting accurate, reliable and verifiable data on the occurrence of hyperglycemia (BG >300 mg/dL), and whether or not CIO is used (immediately before and 72 hours after the BG >300 mg/dl).

02

Conditions studied

  • Hyperglycemia

Browse trials for

03

In context

Hyperglycemia

699 studies on the registry are indexed under Hyperglycemia; 105 are open to participants now.

This study's enrollment of 200 is above the median of 100 across 155 observational studies indexed under Hyperglycemia.

Browse Hyperglycemia studies →

Lead sponsor

HealthPartners Institute is the lead sponsor of 164 studies on the registry; 20 are open to participants now.

Of its 17 completed or terminated interventional studies of FDA-regulated products, 16 (94%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

hospitalized patients with blood glucose >300 mg/dL

Inclusion criteria

  • Park Nicollet Methodist Hospital patient
  • recorded BG > 300 mg/dL during the study data collection period
  • admitted to general floor hospital units

Exclusion criteria

Exclusion Criteria:

  • birth center
  • intensive care units
  • eating disorder unit
  • pediatric patients \< 18 years of age
  • patients receiving insulin infusions
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
200 participants (actual)

Groups and cohorts

  • hyperglycemia

    hospitalized patients with BG \>300 ml/dL

06

What researchers measure

Primary outcomes

  1. glucose levels

    Time frame: 72 hours

Secondary outcomes

  1. type of insulin treatment

    Time frame: 72 hours

07

Study locations

1 site
  • Park Nicollet Methodist Hospital
    Minneapolis, Minnesota 55416, United States
08

References and documents

Publications

  • van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001 Nov 8;345(19):1359-67. doi: 10.1056/NEJMoa011300. PubMed 11794168 ↗
  • Malmberg K, Ryden L, Efendic S, Herlitz J, Nicol P, Waldenstrom A, Wedel H, Welin L. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol. 1995 Jul;26(1):57-65. doi: 10.1016/0735-1097(95)00126-k. PubMed 7797776 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 26, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00813280
Lead sponsor
HealthPartners Institute
Collaborators
International Diabetes Center at Park Nicollet, Park Nicollet Foundation
First posted
Dec 23, 2008
Start date
Jun 2008
Primary completion
Sep 2008
Completion
Dec 2008
Last update
Nov 26, 2015

Study contacts

Lisa Fish, MD
principal investigator · Park Nicollet Health Services Endocrinology
Robert M Cuddihy, MD
principal investigator · International Diabetes Center at Park Nicollet

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2008. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Hyperglycemia→

Other studies from this sponsor

HealthPartners Institute

Start the discussion